Vicenne Charts an Ambitious Path to 2030: Targeting MAD 1.8B Revenue and Regional Healthcare Dominance

Vicenne is setting its sights on aggressive growth through a 'Buy & Build' strategy, targeting MAD 1.8 billion in revenue and MAD 440 million in EBITDA by 2030, up from MAD 1.08 billion and MAD 264 million respectively in 2025. Bolstered by a strong financial position following its IPO, the group plans to expand through targeted acquisitions, organic growth, and international expansion, with a particular focus on becoming a key player in Africa's medical sector while integrating AI into its healthcare services.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.